Skip to search formSkip to main contentSkip to account menu

Silmitasertib

Known as: 5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic Acid 
National Institutes of Health

Related topics

Related topics

1 relation
Silmitasertib Sodium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Silmitasertib. Casein kinase 2 (CK2) inhibitor, Treatment of solid and hematologic malignancies
2017
2017
Abstract 1216: Overcoming cisplatin resistance through the combination treatment with CK2 inhibitor, CX-4945, in gastric cancer
Platinum-based antineoplastic drugs are chemotherapeutic agents to usually treat gastric cancer (GC) include cisplatin. However… 
2016
2016
CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin
Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that are a major cause of mortality of… 
2016
2016
Abstract 5067: Casein kinase 2 alpha phosphorylation of cortactin governs actin cytoskeletal regulation of invadopodia function
Malregulation of signal transduction events controlling cortical actin cytoskeleton dynamics is responsible for to enhancing… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)